tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Vistagen downgraded to Hold at Stifel after PALISADE-3 study disappoints
PremiumThe FlyVistagen downgraded to Hold at Stifel after PALISADE-3 study disappoints
1d ago
Vistagen downgraded to Hold from Buy at Stifel
Premium
The Fly
Vistagen downgraded to Hold from Buy at Stifel
1d ago
Vistagen downgraded to Neutral from Buy at Lucid Capital
Premium
The Fly
Vistagen downgraded to Neutral from Buy at Lucid Capital
1d ago
Vistagen names Nick Tressler CFO
PremiumThe FlyVistagen names Nick Tressler CFO
18d ago
Vistagen presents exploratory PH80 data at Menopause Society meeting
Premium
The Fly
Vistagen presents exploratory PH80 data at Menopause Society meeting
23d ago
VistaGen Therapeutics: Buy Rating Backed by Promising Clinical Trials and Stable Financial Outlook
Premium
Ratings
VistaGen Therapeutics: Buy Rating Backed by Promising Clinical Trials and Stable Financial Outlook
1M ago
VistaGen Completes Patient Phase in Key Clinical Trial
PremiumCompany AnnouncementsVistaGen Completes Patient Phase in Key Clinical Trial
1M ago
VistaGen Therapeutics: Promising Prospects for Fasedienol in Social Anxiety Disorder
Premium
Ratings
VistaGen Therapeutics: Promising Prospects for Fasedienol in Social Anxiety Disorder
1M ago
Vistagen completes portion of PALISADE-3 trial
Premium
The Fly
Vistagen completes portion of PALISADE-3 trial
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100